0      0

133 - Transplantation ~ Novel Immunosuppressive Protocols for Kidney Transplantation and Treatment of Rejection

‐ Apr 8, 2017 10:15am

Credits: None available.

Standard: $ 40.00
Members: $ 30.00

Contact hours available until 9/25/19.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:

• Elizabeth St. John – Employee, Fresenius Kidney Care

• Kyra Trappett – Employee, DaVita Dialysis

There are no other disclosures to declare.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcome:

Nephrology nurses will discuss two new immunosuppressive agents under investigation and describe one protocol to treat rejection.


Credits Available

You must be logged in and own this session in order to post comments.

Perry Bateman
6/7/18 7:39 pm

Excellent presentation, but very complex dosing. I liked at the end it was more interactive.

Karen Nugent
8/4/18 8:21 pm

Very interesting information.

Rosalinda Lopez
8/8/18 9:31 pm

good topic

Sacheene Walker
8/16/18 6:46 pm

Very effective Presentation with lots of pertinent information, learning has certainly taken place

April Pergolotti
8/31/18 2:32 pm

I found this very informative. Very in depth on antirejection drugs and studies. IVIG is something we use at out hospital for autoimmune diseases.